Skip to main content
SpringerLink
Log in

Pharmacological Management of Back Pain Syndromes

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The symptom of back pain may be the result of many different pathologies. As such, patients with back pain require careful assessment to determine whether the cause is from the spine or other systems. For acute mechanical back pain, treatment is often symptomatic.

Symptomatic treatment may include analgesics, anti-inflammatories and/or muscle relaxants. Patients may also need hypnotics in the short term to help them sleep at night. However, drug therapy should be reduced and stopped as soon as possible. Furthermore, too much bedrest may be counterproductive.

Paracetamol (acetaminophen) is the standard treatment for transient back pain. More severe pain may require the addition of an opioid, such as codeine or dextro-propoxyphene. Morphine and pethidine (meperidine) may be necessary in patients with back pain due to neoplastic disease or osteoporotic fracture. However, the opioid analgesics are associated with dependence, tolerance and adverse effects.

Nonsteroidal anti-inflammatory drugs (NSAIDs) have analgesic efficacy comparable with paracetamol. Individual patients respond differently to different NSAIDs, and several agents may have to be tried. Long term therapy with NSAIDs is necessary in diseases with an inflammatory component such as ankylosing spondylitis.

Calcitonin reduces bone resorption and bone blood flow, and has been suggested to have central analgesic effects. As such, it has been used successfully in patients with Paget’s disease, osteolytic bone disease and osteoporosis.

Bisphosphonates also inhibit osteoclastic bone resorption and may be useful in Paget’s disease, osteolytic metastases and osteoporotic fractures.

Other drugs which may be useful in relieving back pain associated with specific circumstances include the tricyclic antidepressants, anxiolytics, antiepileptic agents, corticosteroids, colchicine and chymopapain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Porter RW. Management of back pain. 2nd ed. Edinburgh: Churchill Livingstone 1993, 26, 300

    Google Scholar 

  2. Deyo RA, Diehl AK, Rosenthal M. How many days bed rest for acute back pain?. N Engl J Med 1986; 315: 1064–70

    Article  PubMed  CAS  Google Scholar 

  3. Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. BMJ 1992; 305: 1403–8

    Article  PubMed  CAS  Google Scholar 

  4. Kanis JA, Johnell O, Gullberg B, et al. Bone metabolism in preventing hip fracture. BMJ 1992; 305: 1124–8

    Article  PubMed  CAS  Google Scholar 

  5. Terrell C, Wedley JR. Symptomatic and supportive care In: Rubens RD, Fogelman I, editors. Bone metastases: diagnosis and treatment. London: Springer-Verlag, 1991: 223–4

    Chapter  Google Scholar 

  6. Hadjipavlon A, Lander P. Paget’s disease of the spine. J B Jr Surg 1991; 73a: 1367–81

    Google Scholar 

  7. Kanis JA. Pathophysiology and treatment of Paget’s disease of bone. London: Martin Dunitz, 1992: 1–293

    Google Scholar 

  8. Green DW, O’cConnor L, Hanna M. Efficacy of postoperative pain treatment regimens using both buprenorphine and papaveretum sequentially after abdominal hyspterectomy. Br J Anaesthes 1993; 79: 626–30

    Article  Google Scholar 

  9. Weber H. Comparison of the effects of diazepam and levopromazine on pain in patients with acute lumbago-sciatica syndrome. J Oslo City Hosp 1980; 39: 65–8

    Google Scholar 

  10. Basmajian JV. Acute back pain and spasm. Spine 1989; 14: 438–9

    Article  PubMed  CAS  Google Scholar 

  11. Ward NG. Tricyclic antidepressants for chronic low back pain. Spine 1986; 11: 661–5

    Article  PubMed  CAS  Google Scholar 

  12. Swardlaw M, Cundin JG. Anticonvulsant drugs in the treatment of lancinating pain. A comparison. Anaesthesia 1981; 36: 1129–32

    Article  Google Scholar 

  13. Bush K, Hillier S. A controlled study of caudal epidural injections of triamcinolone plus procaine for the management of intractable sciatica. Spine 1991; 16: 72–5

    Article  Google Scholar 

  14. Andersson KH, Mosdal C. Epidural application of corticosteroids in low back pain and sciatica. Acta Neurochirurg 1987; 87: 52–3

    Article  Google Scholar 

  15. Schnebel BE, Simmonds JW. The use of oral colchicine for low back pain. Spine 1988; 13: 354–7

    Article  PubMed  CAS  Google Scholar 

  16. Ooi Y, Mita F, Nagaslima K. Speculation on the effects and mechanism of calcitonin therapy for claudication due to spinal stenosis. Presented to the International Society for the Study of the Lumbar spine. Boston, June 1990

  17. Martin TJ. Actions of calcitonin and mithramycin. Arthritis Rheum 1980; 23: 1131–7

    Article  PubMed  CAS  Google Scholar 

  18. Civitelli R, Gonelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74

    Article  CAS  Google Scholar 

  19. Douglas DL, Duckworth T, Kanis JA, et al. spinal cord dysfunction in Paget’s disease of bone. J B Jr Surg 1981; 63B: 495–503

    CAS  Google Scholar 

  20. Porter RW, Hibbert C. Calcitonin treatment for neurogenic claudication. Spine 1983; 8: 585–92

    Article  PubMed  CAS  Google Scholar 

  21. Porter RW, Miller C. Neurogenic claudication and root claudication treated with calcitonin. Spine 1988; 13: 1062–4

    Article  Google Scholar 

  22. Eskola A, Alarantara H, Poljolainen T, et al. Calcitonin treatment in lumbar stenosis: clinical observations. Calcif Tissue Int 1989; 45: 372–4

    Article  PubMed  CAS  Google Scholar 

  23. Streifler T, Hering R, Gadoth N. Calcitonin for pseudoclaudication in lumbar spinal stenosis. Neurol Neurosurg Psychiatr 1989; 52: 543–4

    Article  CAS  Google Scholar 

  24. Fleish H. Bisphosphonates: Mechanisms of action and clinical applications. In: Peck WA, editor. Bone and mineral research, Annual 1. Amsterdam: Excerpta Medica, 1982: 319–57

    Google Scholar 

  25. Gallacher SJ, Boyce BF, Patel U, et al. Clinical experience with Pamidronate in the treatment of Paget’s disease of bone. Ann Rheum Dis 1991; 50: 930–3

    Article  PubMed  CAS  Google Scholar 

  26. Boyce BF, Smith ML, Fogelman I, et al. Diphosphonates and inhibition of bone mineralisation. Lancet 1982; 1: 964–5

    Article  PubMed  CAS  Google Scholar 

  27. Lahtinen R, Laasko M, Palva I, et al. Randomised placebo controlled multicentre trial of clodronate in multiple myeloma. Lancet 1992; 340: 1049–52

    Article  PubMed  CAS  Google Scholar 

  28. van Holter-Verzantvoort ATh, Bijvoet OLM, Hermans J, et al. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet 1987; 2: 983–5

    Article  Google Scholar 

  29. Storm T, Thamsborg G, Steiniche T, et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with post-menopausal osteoporosis. N Engl J Med 1990; 322: 1265–71

    Article  PubMed  CAS  Google Scholar 

  30. Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of post-menopausal osteoporosis. N Engl J Med 1990; 323: 73–9

    Article  PubMed  CAS  Google Scholar 

  31. Dando PM, Jenner JR, Charles A, et al. Lost dose, low volume chemonucleolysis. Spine 1992; 17: 56–8

    Article  PubMed  CAS  Google Scholar 

  32. McCulloch JA. Chemonucleolysis: Experience with 2000 cases. Clin Orthop 1980; 146: 128–35

    PubMed  Google Scholar 

  33. Cogain WT, Fraser RD. Cymopapain: a ten year double blind study. Spine 1992; 17: 388–94

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedics, Medical School, University of Aberdeen, Foresterhill, Aberdeen, AB9 2ZD, Scotland

    R. W. Porter

  2. Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland

    Stuart H. Ralston

Authors
  1. R. W. Porter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stuart H. Ralston
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porter, R.W., Ralston, S.H. Pharmacological Management of Back Pain Syndromes. Drugs 48, 189–198 (1994). https://doi.org/10.2165/00003495-199448020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199448020-00006

Keywords

Search

Navigation